ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 597,52
-0,23%
Dow Jones
42 063,36
0,09%
DAX
18 720,01
-1,47%
Brent Oil
74,135
0,00%
Bitcoin
62 925,91
-0,71%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. T2 Biosystems Inc (TTOO)

  7. T2 Biosystems Inc (TTOO) Actualités

TTOO

T2 Biosystems (TTOO)

T2 Biosystems Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:TTOO
DateHeureSourceTitreSymboleSociété
20/09/202415h00GlobeNewswire Inc.T2 Biosystems Achieves Successful Defense of Patent for Direct-From-Whole Blood Pathogen Detection Method in the European UnionNASDAQ:TTOOT2 Biosystems Inc
20/09/202414h59Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TTOOT2 Biosystems Inc
16/09/202415h00GlobeNewswire Inc.T2 Biosystems Receives FDA Clearance to Market the T2Candida Panel for Pediatric PatientsNASDAQ:TTOOT2 Biosystems Inc
09/09/202415h00GlobeNewswire Inc.T2 Biosystems Provides Updates on its New Product Development Pipeline ProgressNASDAQ:TTOOT2 Biosystems Inc
27/08/202422h05GlobeNewswire Inc.T2 Biosystems to Participate in the H.C. Wainwright 26th Annual Global Investment ConferenceNASDAQ:TTOOT2 Biosystems Inc
23/08/202422h31Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:TTOOT2 Biosystems Inc
08/08/202422h49Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TTOOT2 Biosystems Inc
01/08/202422h05GlobeNewswire Inc.T2 Biosystems to Attend Upcoming Investor ConferencesNASDAQ:TTOOT2 Biosystems Inc
30/07/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:TTOOT2 Biosystems Inc
29/07/202422h05GlobeNewswire Inc.T2 Biosystems Announces Second Quarter 2024 Financial ResultsNASDAQ:TTOOT2 Biosystems Inc
29/07/202422h02GlobeNewswire Inc.T2 Biosystems Announces Commercial Expansion Through Malaysia and Indonesia DistributorNASDAQ:TTOOT2 Biosystems Inc
22/07/202422h05GlobeNewswire Inc.T2 Biosystems to Report Second Quarter 2024 Financial Results and Business Updates on July 29, 2024NASDAQ:TTOOT2 Biosystems Inc
19/07/202423h04Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:TTOOT2 Biosystems Inc
25/06/202415h00GlobeNewswire Inc.T2 Biosystems Announces Commercial Expansion Through Hong Kong and Macau DistributorNASDAQ:TTOOT2 Biosystems Inc
22/05/202415h00GlobeNewswire Inc.T2 Biosystems Regains Compliance with Nasdaq Continued Listing RequirementsNASDAQ:TTOOT2 Biosystems Inc
17/05/202422h05GlobeNewswire Inc.T2 Biosystems Announces Closing of $8 Million Private Placement Priced At-The-Market Under Nasdaq RulesNASDAQ:TTOOT2 Biosystems Inc
15/05/202413h00GlobeNewswire Inc.T2 Biosystems Announces $8 Million Private Placement Priced At-The-Market Under Nasdaq RulesNASDAQ:TTOOT2 Biosystems Inc
14/05/202423h00GlobeNewswire Inc.T2 Biosystems Announces CRG’s Conversion from Preferred Stock to Common StockNASDAQ:TTOOT2 Biosystems Inc
14/05/202422h55Edgar (US Regulatory)Form RW - Registration Withdrawal RequestNASDAQ:TTOOT2 Biosystems Inc
14/05/202401h21Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:TTOOT2 Biosystems Inc
14/05/202400h19Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TTOOT2 Biosystems Inc
07/05/202415h00GlobeNewswire Inc.T2 Biosystems Announces Letter of Intent to Enter Strategic Partnership for Lyme DiseaseNASDAQ:TTOOT2 Biosystems Inc
06/05/202423h27Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:TTOOT2 Biosystems Inc
06/05/202422h34GlobeNewswire Inc.T2 Biosystems Announces First Quarter 2024 Financial ResultsNASDAQ:TTOOT2 Biosystems Inc
06/05/202422h34GlobeNewswire Inc.T2 Biosystems Announces Commercial Expansion Through Middle East DistributorNASDAQ:TTOOT2 Biosystems Inc
06/05/202422h29GlobeNewswire Inc.T2 Biosystems Announces the Conversion of an Additional $15 Million of CRG Term Loan into EquityNASDAQ:TTOOT2 Biosystems Inc
24/04/202415h00GlobeNewswire Inc.T2 Biosystems to Report First Quarter 2024 Financial Results and Business Updates on May 6, 2024NASDAQ:TTOOT2 Biosystems Inc
11/04/202422h05GlobeNewswire Inc.T2 Biosystems Shareholders Vote for CRG Debt Conversion into EquityNASDAQ:TTOOT2 Biosystems Inc
28/03/202414h00GlobeNewswire Inc.T2 Biosystems Announces Extension of Multi-Year Capital Equipment Supplier Agreement with Vizient, Inc.NASDAQ:TTOOT2 Biosystems Inc
20/03/202412h30GlobeNewswire Inc.T2 Biosystems Unveils T2Lyme Launch Plans and Provides Additional Business UpdatesNASDAQ:TTOOT2 Biosystems Inc
 Showing the most relevant articles for your search:NASDAQ:TTOO

Dernières Valeurs Consultées

COIN
MOONZUSD
The Other Side Token
NYSE
HELO
J.P. Morgan Exch
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés